Who Buys Mitomycin from India — 456 Importers Behind a $8.2M Market
India's mitomycin import market is served by 456 active buyers who collectively imported $8.2M across 1,333 shipments. RX CROSSROADS 3PL LLC (UNITED STATES) leads with a 21.8% market share, followed by RXCROSSROADS 3PL LLC and FOUNDATION CARE. The top 5 buyers together control 43.3% of total import value, reflecting a moderately competitive buyer landscape.
Mitomycin buyer data — 456 importers · $8.2M market · 1,333 shipmentsTransData Nexus · Indian Customs Data
Top Mitomycin Importers — Ranked by Import Value
RX CROSSROADS 3PL LLC (UNITED STATES) is the leading mitomycin importer from India, holding a 21.8% share of the $8.2M market across 1,333 shipments from 456 buyers. The top 5 buyers — RX CROSSROADS 3PL LLC (UNITED STATES), RXCROSSROADS 3PL LLC (UNITED STATES), FOUNDATION CARE (UNITED STATES), PHARMACIE CENTRALE DES HOPITAUX (PC (ALGERIA), EVERSANA LIFE SCIENCES SERVICES,LLC (UNITED STATES) — collectively control 43.3% of total import value.
Top Mitomycin Buyers & Importers
Ranked by import value · 456 active buyers · Indian Customs (DGFT) data
Mar 2026
Top Mitomycin Buyers & Importers — Ranked by Import Value. 456 active buyers with import value, shipments, country and supplier data compiled from Indian Customs records by TransData Nexus.
Which companies are buying Mitomycin — and from which countries?
Flow of Mitomycin exports from India: each country's share and the named importers behind the numbers
Mitomycin — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Top 5 importing countries account for 83.2% of global Mitomycin imports — led by United States (63.5%) with a total trade value of $8.2M across 1,333 shipments from India.
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $5.2M through 57 shipments. This represents a market share of 63.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• RX CROSSROADS 3PL LLC - $1.8M (34.3% of country's total business)
• RXCROSSROADS 3PL LLC - $643.8K (12.4% of country's total business)
• FOUNDATION CARE - $432.5K (8.3% of country's total business)
• EVERSANA LIFE SCIENCES SERVICES,LLC - $290.9K (5.6% of country's total business)
• EUGIA US LLC - $242.5K (4.7% of country's total business)
• Rest of United States's importers - $1.8M (34.6% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $90.9K, indicating premium pricing strategy compared to the market average of $6.1K.
United States is a key market for Mitomycin imports, representing 63.5% of total trade value.
Mitomycin imports from India are distributed among various buyer segments, each with distinct purchasing behaviors:
Distributors: Entities like RX Crossroads 3PL LLC and Eversana Life Sciences Services, LLC in the United States fall into this category. They procure large volumes to supply hospitals, clinics, and pharmacies, often engaging in long-term contracts to ensure consistent supply chains.
Hospital Groups: Organizations such as Pharmacie Centrale des Hôpitaux (Algeria) represent this segment. They purchase Mitomycin directly for use within their network of hospitals, focusing on bulk procurement to meet patient needs efficiently.
Retail Chains: While not prominently featured among the top buyers, retail chains may procure Mitomycin to stock in pharmacies, catering to outpatient prescriptions. Their orders are typically smaller and more frequent, aligning with consumer demand.
Government Procurement: Entities like Kyowa Kirin Co Ltd (Japan) may participate in national tenders to supply public healthcare facilities. Their procurement is often characterized by large, periodic orders aligned with government healthcare initiatives.
Understanding the import regulations for Mitomycin in the top five importing countries is crucial:
United States:
Regulatory Authority: Food and Drug Administration (FDA).
Import Registration Process: Importers must ensure that Mitomycin is FDA-approved. The process involves submitting a New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) for generic versions.
Estimated Timeline: The approval process can range from 10 months to several years, depending on the application type and completeness.
Import Tariff/Duty: Pharmaceutical products under HS Code 30049049 are generally duty-free, but importers should verify current tariffs with U.S. Customs and Border Protection.
Several factors drive the demand for Mitomycin across importing countries:
Disease Prevalence: Mitomycin is primarily used in oncology, particularly for treating certain types of cancer. The global rise in cancer incidence, as reported by the World Health Organization (WHO), underscores the increasing need for effective chemotherapeutic agents.
Government Healthcare Programs: Many countries have national health programs that subsidize or fully cover cancer treatments, enhancing patient access to medications like Mitomycin.
Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased procurement of essential medicines, including Mitomycin, to ensure comprehensive care.
WHO Essential Medicines List Procurement: Mitomycin's inclusion in the WHO Essential Medicines List facilitates its procurement by governments and international organizations, ensuring availability in public health systems.
Common Questions — Mitomycin Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest mitomycin buyer importing from India?
Based on import volume and value, RX CROSSROADS 3PL LLC (UNITED STATES) leads with $1.8M in imports and a 21.8% market share — the highest of any single mitomycin importer. RXCROSSROADS 3PL LLC (UNITED STATES) and FOUNDATION CARE (UNITED STATES) are the next largest buyers.
QHow many companies buy mitomycin from India?
There are 456 active mitomycin buyers importing from India, with a combined market of $8.2M across 1,333 shipments to 103 countries. The top 5 buyers hold 43.3% of total import value, while the remaining 451 buyers handle the other 56.7%.
QWhich countries import the most mitomycin from India?
The top importing countries for mitomycin from India are United States (63.5%), Algeria (7.5%), Thailand (5.2%), Japan (3.9%), Canada (3.0%). These markets represent the largest demand centres for Indian pharmaceutical exports of mitomycin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for mitomycin from India?
The average import transaction value for mitomycin from India is $6.1K, with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Mitomycin imports from India are distributed among various buyer segments, each with distinct purchasing behaviors:
Distributors: Entities like RX Crossroads 3PL LLC and Eversana Life Sciences Services, LLC in the United States fall into this category. They procure large volumes to supply hospitals, clinics, and pharmacies, often engaging in long-term contracts to ensure consistent supply chains.
Hospital Groups: Organizations such as Pharmacie Centrale des Hôpitaux (Algeria) represent this segment. They purchase Mitomycin directly for use within their network of hospitals, focusing on bulk procurement to meet patient needs efficiently.
Retail Chains: While not prominently featured among the top buyers, retail chains may procure Mitomycin to stock in pharmacies, catering to outpatient prescriptions. Their orders are typically smaller and more frequent, aligning with consumer demand.
Government Procurement: Entities like Kyowa Kirin Co Ltd (Japan) may participate in national tenders to supply public healthcare facilities. Their procurement is often characterized by large, periodic orders aligned with government healthcare initiatives.
Understanding the import regulations for Mitomycin in the top five importing countries is crucial:
United States:
Regulatory Authority: Food and Drug Administration (FDA).
Import Registration Process: Importers must ensure that Mitomycin is FDA-approved. The process involves submitting a New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) for generic versions.
Estimated Timeline: The approval process can range from 10 months to several years, depending on the application type and completeness.
Import Tariff/Duty: Pharmaceutical products under HS Code 30049049 are generally duty-free, but importers should verify current tariffs with U.S. Customs and Border Protection.
Several factors drive the demand for Mitomycin across importing countries:
Disease Prevalence: Mitomycin is primarily used in oncology, particularly for treating certain types of cancer. The global rise in cancer incidence, as reported by the World Health Organization (WHO), underscores the increasing need for effective chemotherapeutic agents.
Government Healthcare Programs: Many countries have national health programs that subsidize or fully cover cancer treatments, enhancing patient access to medications like Mitomycin.
Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased procurement of essential medicines, including Mitomycin, to ensure comprehensive care.
WHO Essential Medicines List Procurement: Mitomycin's inclusion in the WHO Essential Medicines List facilitates its procurement by governments and international organizations, ensuring availability in public health systems.
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
2Algeria
Algeria emerges as the second largest importing country, achieving a total trade value of $611.7K through 9 shipments. This represents a market share of 7.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Algeria has a diverse importer base, with their top importers including:
• PHARMACIE CENTRALE DES HOPITAUX (PC - $389.6K (63.7% of country's total business)
• PHARMACIE CENTRALE DES HOPITAUX - $148.7K (24.3% of country's total business)
• PHARMACIE CENTRALE DES HOPITAUX (P - $73.4K (12.0% of country's total business)
Key Insight: Algeria demonstrates strong market positioning with an average shipment value of $68.0K, indicating premium pricing strategy compared to the market average of $6.1K.
Algeria is a key market for Mitomycin imports, representing 7.5% of total trade value.
Primary Market
Secondary Market
3Thailand
Thailand emerges as the third largest importing country, achieving a total trade value of $427.5K through 13 shipments. This represents a market share of 5.2% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Thailand has a diverse importer base, with their top importers including:
• ATLANTA MEDICARE CO LTD - $226.0K (52.9% of country's total business)
• ATLANTA MEDICARE CO. LTD. - $149.1K (34.9% of country's total business)
Key Insight: Thailand demonstrates strong market positioning with an average shipment value of $32.9K, indicating premium pricing strategy compared to the market average of $6.1K.
Thailand is a key market for Mitomycin imports, representing 5.2% of total trade value.
Primary Market
Secondary Market
4Japan
Japan emerges as the fourth largest importing country, achieving a total trade value of $322.0K through 5 shipments. This represents a market share of 3.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Japan has a diverse importer base, with their top importers including:
• KYOWA KIRIN CO LTD - $215.7K (67.0% of country's total business)
• XXOWAXXIRIXXCO XXLIMITEDX - $88.9K (27.6% of country's total business)
Key Insight: Japan demonstrates strong market positioning with an average shipment value of $64.4K, indicating premium pricing strategy compared to the market average of $6.1K.
Japan is a key market for Mitomycin imports, representing 3.9% of total trade value.
Primary Market
Secondary Market
5Canada
Canada emerges as the fifth largest importing country, achieving a total trade value of $245.8K through 0 shipments. This represents a market share of 3.0% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Canada demonstrates strong market positioning with an average shipment value of $245.8K, indicating premium pricing strategy compared to the market average of $6.1K.
Canada is a key market for Mitomycin imports, representing 3.0% of total trade value.
Primary Market
Secondary Market
Re-exporters: Companies such as Atlanta Medicare Co Ltd (Thailand) might import Mitomycin not only for domestic use but also for re-export to neighboring countries, leveraging regional trade agreements.
Contract Manufacturers: Firms like Eugia US LLC (United States) may import Mitomycin as an active pharmaceutical ingredient (API) for formulation into finished products, adhering to stringent quality standards and regulatory requirements.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Regulatory Authority: Agence Nationale des Produits Pharmaceutiques (ANPP).
Import Registration Process: Requires submission of a dossier including product information, clinical data, and manufacturing details.
Estimated Timeline: Typically 12 to 18 months for approval.
Import Tariff/Duty: Pharmaceuticals may be subject to a value-added tax (VAT) and customs duties; specific rates should be confirmed with Algerian customs authorities.
Thailand:
Regulatory Authority: Thai Food and Drug Administration (Thai FDA).
Import Registration Process: Involves product registration, including submission of quality, safety, and efficacy data.
Estimated Timeline: Approximately 12 to 24 months.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049049 are generally exempt from import duties, but VAT applies.
Japan:
Regulatory Authority: Pharmaceuticals and Medical Devices Agency (PMDA).
Import Registration Process: Requires submission of a Marketing Authorization Application (MAA) with comprehensive data.
Estimated Timeline: 12 to 18 months.
Import Tariff/Duty: Pharmaceuticals are typically duty-free, but consumption tax applies.
Canada:
Regulatory Authority: Health Canada.
Import Registration Process: Submission of a New Drug Submission (NDS) or Abbreviated New Drug Submission (ANDS) is required.
Estimated Timeline: Approximately 12 to 18 months.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049049 are generally duty-free, but Goods and Services Tax (GST) applies.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Tender-Based Purchasing: Many countries utilize tender systems for bulk purchasing of pharmaceuticals, promoting competitive pricing and consistent supply.
With 456 buyers across 103 countries, the global market for Mitomycin presents significant opportunities for suppliers, especially in regions with expanding healthcare infrastructure and increasing cancer prevalence.
TransData Nexus Research · Government and regulatory sourcesMar 2026
$13.79 per unit
Re-exporters: Companies such as Atlanta Medicare Co Ltd (Thailand) might import Mitomycin not only for domestic use but also for re-export to neighboring countries, leveraging regional trade agreements.
Contract Manufacturers: Firms like Eugia US LLC (United States) may import Mitomycin as an active pharmaceutical ingredient (API) for formulation into finished products, adhering to stringent quality standards and regulatory requirements.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Regulatory Authority: Agence Nationale des Produits Pharmaceutiques (ANPP).
Import Registration Process: Requires submission of a dossier including product information, clinical data, and manufacturing details.
Estimated Timeline: Typically 12 to 18 months for approval.
Import Tariff/Duty: Pharmaceuticals may be subject to a value-added tax (VAT) and customs duties; specific rates should be confirmed with Algerian customs authorities.
Thailand:
Regulatory Authority: Thai Food and Drug Administration (Thai FDA).
Import Registration Process: Involves product registration, including submission of quality, safety, and efficacy data.
Estimated Timeline: Approximately 12 to 24 months.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049049 are generally exempt from import duties, but VAT applies.
Japan:
Regulatory Authority: Pharmaceuticals and Medical Devices Agency (PMDA).
Import Registration Process: Requires submission of a Marketing Authorization Application (MAA) with comprehensive data.
Estimated Timeline: 12 to 18 months.
Import Tariff/Duty: Pharmaceuticals are typically duty-free, but consumption tax applies.
Canada:
Regulatory Authority: Health Canada.
Import Registration Process: Submission of a New Drug Submission (NDS) or Abbreviated New Drug Submission (ANDS) is required.
Estimated Timeline: Approximately 12 to 18 months.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049049 are generally duty-free, but Goods and Services Tax (GST) applies.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Tender-Based Purchasing: Many countries utilize tender systems for bulk purchasing of pharmaceuticals, promoting competitive pricing and consistent supply.
With 456 buyers across 103 countries, the global market for Mitomycin presents significant opportunities for suppliers, especially in regions with expanding healthcare infrastructure and increasing cancer prevalence.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Analysis Methodology
1.Buyer Identification: 456 global importers of Mitomycin identified from consignee fields in DGFT shipping bill records.
2.Import Value Analysis: Total import value aggregated from 1,333 individual shipping bill records. Values are FOB in USD.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
4.Geographic Distribution: Buyer imports distributed across 103 destination countries with market share per buyer calculated from capped values.
